Results 151 to 160 of about 15,201 (184)

Circulating metabolites and bladder cancer: a Mendelian randomization and multi-omics study. [PDF]

Discov Oncol
Chang Z, Wang J, Wang L, Hu Z, Chen S, Yang L.   +5 more
europepmc   +1 more source

DCUN1D5 is a novel potential biomarker for predicting the prognosis of bladder cancer. [PDF]

Discov Oncol
Han X, Li L, Jia Y, Ai L, Wang X, Xu C, Guo R, Wu R, Dong Y, Fang S, Li R, Zhang J, Luo J, Zhou Z, Wei Y, Yang L, Ju H, Ma Q, Zheng K.   +18 more
europepmc   +1 more source

Macrophage Cell and Diagnostic Biomarkers in BLCA: Integrating Machine Learning With Single-Cell Analysis

Clinical Genitourinary Cancer
Guangliang Che, Xuejun Zhao, Rongtuan Luo, Quanfeng Yu, Xiaofeng Guo, Ke Gao, Kangyu Chen, Erfeng Zhang   +7 more
openaire   +1 more source

Novel Biomarkers for Lymph Node Metastasis and Prognosis of Bladder Cancer by Bioinformatics Analysis. [PDF]

ACS Omega
Sun Y, Ding M, Sun J, Zhang Q, Cao W, Chen W, Wang X, Diao W, Guo H.   +8 more
europepmc   +1 more source

Znaczenie białka macierzy jądrowej BLCA-4 w raku pęcherza moczowego

Postępy Higieny i Medycyny Doświadczalnej, 2017
openaire   +1 more source

A novel prognostic model based on epithelial cell progression genes identifies OAS1 as a suppressor of bladder cancer aggressiveness. [PDF]

Front Mol Biosci
Su X, Yu H, Zhang M, Zeng K, Zhong F, Chen X, Guo Y, Lin L.   +7 more
europepmc   +1 more source

A GRK5 centered prognostic framework for bladder cancer based on palmitoylation and epigenetic regulation. [PDF]

Discov Oncol
Liu J, Zhang Z, Huang B, Fang Y, Lin H.
europepmc   +1 more source

Downregulated of CTGF reveals mechanism, remodels immune microenvironment, modulates drug sensitivity in bladder cancer. [PDF]

Future Sci OA
Zhang H, Tang K, Chen Y, Chen G, Tan G, Dong Y, Ling J, He R, Qin D, He J, Li S, Dang Y, Chen G, Feng Z, Deng L.   +14 more
europepmc   +1 more source

ERBB2 mutations promote recurrence and metastasis in non-muscle-invasive bladder cancer via HIF-1 phosphorylation: Insights from whole exome sequencing. [PDF]

J Pharm Anal
Wang X, Jin L, Zou X, Zhu A, Li M, Fan H.   +5 more
europepmc   +1 more source

Correction: miR-145-Mediated Tumor Suppression in Bladder Urothelial Carcinoma via Targeting the ADAMTS5/Wnt Signaling Axis. [PDF]

Cureus
Wei J, Feng ZL, Mao CY, Xi H, Ming F, Jun C.   +5 more
europepmc   +1 more source